Endothelial sodium channels trigger endothelial salt sensitivity with aging

Hypertension

Volumn 64, Issue 2, 2014, Pages 391-396

  Paar, Moritz ^a   Pavenstädt, Hermann ^b   Kusche Vihrog, Kristina ^a   Drüppel, Verena ^a   Oberleithner, Hans ^a   Kliche, Katrin ^b  

^a Institute of Physiology II   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

aging; endothelium, vascular; sodium channels

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMILORIDE; EPITHELIAL SODIUM CHANNEL; SODIUM; SPIRONOLACTONE;

AGING; ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORTICAL STIFFNESS; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL SALT SENSITIVITY; ENDOTHELIUM CELL; EX VIVO STUDY; HYPERTENSION; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

AGING; ENDOTHELIUM, VASCULAR; SODIUM CHANNELS;

AGING; AMILORIDE; ANIMALS; AORTA; ENDOTHELIUM, VASCULAR; EPITHELIAL SODIUM CHANNELS; MICE; SODIUM CHLORIDE; SPIRONOLACTONE; VASCULAR STIFFNESS;

EID: 84904512347     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03348     Document Type: Article

References (42)

1. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(6 pt 2):II127-II134.
2. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27(3 pt 2):481-490.
3. Larrousse M, Bragulat E, Segarra M, Sierra C, Coca A, de La Sierra A. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Am J Hypertens. 2006;19:87-93.
4. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37(2 pt 2):429-432.
5. Oberleithner H, Riethmüller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA. 2007;104:16281-16286.
6. Rizzo V, McIntosh DP, Oh P, Schnitzer JE. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem. 1998;273:34724-34729.
7. Kliche K, Jeggle P, Pavenstädt H, Oberleithner H. Role of cellular mechanics in the function and life span of vascular endothelium. Pflugers Arch. 2011;462:209-217.
8. Kusche-Vihrog K, Jeggle P, Oberleithner H. The role of ENaC in vascular endothelium. Pflugers Arch. 2013;10:1356-1363.
9. Warnock DG, Kusche-Vihrog K, Tarjus A, Sheng S, Oberleithner H, Kleyman TR, Jaisser F. Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells. Nat Rev Nephrol. 2014;10:146-157.
10. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun. 2001;280:1300-1306.
11. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
12. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res. 2005;66:286-294.
13. Osanai T, Kanazawa T, Yokono Y, Uemura T, Okuguchi T, Onodera K. [Effect of aging on sensitivity of blood pressure to salt]. Nihon Ronen Igakkai Zasshi. 1993;30:30-34.
14. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66:2454-2466.
15. Kusche-Vihrog K, Urbanova K, Blanqué A, Wilhelmi M, Schillers H, Kliche K, Pavenstädt H, Brand E, Oberleithner H. C-reactive protein makes human endothelium stiff and tight. Hypertension. 2011;57:231-237.
16. Drüppel V, Kusche-Vihrog K, Grossmann C, Gekle M, Kasprzak B, Brand E, Pavenstädt H, Oberleithner H, Kliche K. Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome. FASEB J. 2013;27:3652-3659.
17. Feng M, DiPetrillo K. Non-invasive blood pressure measurement in mice. Methods Mol Biol. 2009;573:45-55.
18. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454-462.
19. Barton M. Aging and biomedicine 2005: where should we go from here? Cardiovasc Res. 2005;66:187-189.
20. de Magalhães JP. Programmatic features of aging originating in development: aging mechanisms beyond molecular damage? FASEB J. 2012;26:4821-4826.
21. Krug AW, Allenhöfer L, Monticone R, Spinetti G, Gekle M, Wang M, Lakatta EG. Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signalregulated kinase ? mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension. 2010;55:1476-1483.
22. Jeggle P, Callies C, Tarjus A, Fassot C, Fels J, Oberleithner H, Jaisser F, Kusche-Vihrog K. Epithelial sodium channel stiffens the vascular endothelium in vitro and in Liddle mice. Hypertension. 2013;61:1053-1059.
23. Fels J, Jeggle P, Kusche-Vihrog K, Oberleithner H. Cortical actin nanodynamics determines nitric oxide release in vascular endothelium. PLoS One. 2012;7:e41520.
24. Mazzochi C, Bubien JK, Smith PR, Benos DJ. The carboxyl terminus of the alpha-subunit of the amiloride-sensitive epithelial sodium channel binds to F-actin. J Biol Chem. 2006;281:6528-6538.
25. Oberleithner H, Kusche-Vihrog K, Schillers H. Endothelial cells as vascular salt sensors. Kidney Int. 2010;77:490-494.
26. Korte S, Wiesinger A, Straeter AS, Peters W, Oberleithner H, Kusche-Vihrog K. Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis. Pflugers Arch. 2012;463:269-278.
27. Maurya PK, Prakash S. Decreased activity of Ca(++)-ATPase and Na(+)/K(+)-ATPase during aging in humans. Appl Biochem Biotechnol. 2013;170:131-137.
28. Sokolov I, Iyer S, Woodworth CD. Recovery of elasticity of aged human epithelial cells in vitro. Nanomedicine. 2006;2:31-36.
29. Lieber SC, Aubry N, Pain J, Diaz G, Kim SJ, Vatner SF. Aging increases stiffness of cardiac myocytes measured by atomic force microscopy nanoindentation. Am J Physiol Heart Circ Physiol. 2004;287:H645-H651.
30. Lee JH, Chung KY, Bang D, Lee KH. Searching for aging-related proteins in human dermal microvascular endothelial cells treated with anti-aging agents. Proteomics. 2006;6:1351-1361.
31. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.
32. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med. 1992;120:893-901.
33. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension. 2002;39(2 pt 2):614-618.
34. Funder JW. The case against aldosterone: not proven. Endocrine. 2012;42:464-465.
35. Funder JW. Relative aldosterone excess: relative to what? Hypertension. 2005;46:643-644.
36. Weidmann P, De Myttenaere-Bursztein S, Maxwell MH, de Lima J. Effect on aging on plasma renin and aldosterone in normal man. Kidney Int. 1975;8:325-333.
37. O'Connor KA, Cotter PE, Kingston M, Twomey C, O'Mahony D. The pattern of plasma sodium abnormalities in an acute elderly care ward: a cross-sectional study. Ir J Med Sci. 2006;175:28-31.
38. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337:169-172.
39. Forrest G, McInnes GT, Fairhead AP, Thompson GG, Brodie MJ. Simple high-performance liquid chromatographic method for the measurement of amiloride in body fluids. J Chromatogr. 1988;428:123-130.
40. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1997;17:1152-1156.
41. Kithas PA, Supiano MA. Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. J Am Geriatr Soc. 2010;58:1327-1332.
42. Lacolley P, Safar ME, Lucet B, Ledudal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol. 2001;37:662-667.